XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2022
USD ($)
candidate
subsidiary
Dec. 31, 2021
USD ($)
Mar. 10, 2021
subject
trial
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Number of additional trials | trial     3
Number of clinical trial subjects | subject     1,000
Number of product candidates | candidate 4    
Number of subsidiaries | subsidiary 3    
Accumulated deficit $ 696,331 $ 674,547  
Cash, cash equivalents and marketable securities $ 77,398 $ 87,326